Cold Pain Therapy Market - Study of Hip and Knee Surgeries and Sports Medicine to 2023
Top players operating in cold pain therapy market are Sanofi (France), DJO Finance (US), Pfizer (US), 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany), Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India).
Download Free Brochure of Cold Pain Therapy Market with 273 Pages, Profiling 15 Companies at http://www.reportsnreports.com/contacts/requestsample.aspx?name=718464 .
Cold pain therapy market report studies factors affecting market growth. It analyzes opportunities & challenges in market & provides details of competitive landscape for market leaders. Report analyzes micro markets with respect to their individual growth trends. Cold pain therapy market is segmented into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy on the basis of application.
Recent Developments
1 Key Drivers in the Cold Pain Therapy Market (2018-2023)
2 Global Cold Pain Therapy Market, By Product 2018 vs 2023 (USD Million)
3 Global Cold Pain Therapy Market: By Application (2018 vs 2023)
4 North America to Hold the Largest Market Share in the Cold Pain Therapy Market in 2018
5 Asia-Pacific to Register the Highest CAGR in Cold Pain Therapy Market During the Forecast Period (2018–2023)
Click Here For More Information on Cold Pain Therapy Market Top Trends and Company Profiles at https://www.prnewswire.co.uk/news-releases/cold-pain-therapy-market-to-grow-steady-at-46-cagr-to-2023-globally-685564721.html .
The global cold pain therapy market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period.
Cold pain therapy market is categorized into OTC products and prescription products. In 2018, OTC products segment is expected to account for the largest share. The large share can be attributed to factors such as high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use.
Report studies the cold pain therapy market based on product, application, and region. The report also studies factors affecting market growth; it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends.
